Notícias

The recent COronaVIrus Disease (COVID)-19 pandemic has placed an unprecedented burden on the drug development opportunity to prevent the onset...

Human coronaviruses present a substantial global disease burden, causing damage to populations’ health, economy, and social well-being. Glycans are one...

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes coronavirus disease 2019 (COVID-19). SARS-CoV-2 enters host cells by binding with the...

Patients with underlying medical conditions are at increased risk for severe coronavirus disease 2019 (Covid-19). Whereas vaccine-derived immunity develops over...

An ideal therapeutic anti-SARS-CoV-2 antibody would resist viral escape1,2,3, have activity against diverse sarbecoviruses4,5,6,7, and be highly protective through viral...

A Anvisa realiza no dia 19 de julho, segunda-feira, webinar sobre as alterações a serem implementadas nas normas para registro...

Development of an effective antiviral drug for Coronavirus Disease 2019 (COVID-19) is a global health priority. Although several candidate drugs...

The emergency use authorization of two mRNA vaccines in less than a year from the emergence of SARS-CoV-2 represents a...

ITF Chemical, 21 anos de Investimentos na Bahia. Honestidade, respeito,
responsabilidade, foco e inovação são a base sobre a...

ABIFINA marca presença na Semana da OCDE e Indústria – Missão Virtual realizada
pela CNI para promover o encontro...

Improving clinical care for individuals infected with SARS-CoV-2 variants is a global health priority. Small-molecule antivirals like remdesivir (RDV) and...

The COVID-19 pandemic caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has quickly spread around the globe. At...